BRITISH THORACIC ONCOLOGY GROUP
Financial health, per its FY2025 accounts
The accounts state that total income increased significantly to £1,696,222, resulting in a net surplus of £172,212 for the year. The charity holds free unrestricted reserves of £717,389, which the trustees acknowledge is significantly below their long-term target level. The trustees are considering measures to build up these reserves while maintaining adequate resources for operational existence.
What the accounts disclose
“the trustees have agreed that at any one time the charity can hold a maximum of 2 years’ normal operating expenditure in reserve.” — page 31
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Denis Talbot
- Jacqueline Fenemore
- Karen Lisa Chadwick
- Nicholas Roberts
- Professor Corinne Faivre-Finn
- Professor Michael Peake OBE
- Vanessa Beattie
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £1.7m | £1.5m |
| 31/03/2024 | £765k | £780k |
| 31/03/2023 | £138k | £317k |
| 31/03/2022 | £527k | £287k |
| 31/03/2021 | £20k | £144k |
Common questions
Is BRITISH THORACIC ONCOLOGY GROUP financially healthy?
The accounts state that total income increased significantly to £1,696,222, resulting in a net surplus of £172,212 for the year. The charity holds free unrestricted reserves of £717,389, which the trustees acknowledge is significantly below their long-term target level. The trustees are considering measures to build up these reserves while maintaining adequate resources for operational existence. Its FY2025 accounts were audited by Newby Castleman LLP.